These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1119 related articles for article (PubMed ID: 27005906)
41. Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics. Ammar HO; Tadros MI; Salama NM; Ghoneim AM Int J Nanomedicine; 2020; 15():5671-5685. PubMed ID: 32821096 [TBL] [Abstract][Full Text] [Related]
42. Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications. Sahle FF; Gerecke C; Kleuser B; Bodmeier R Int J Pharm; 2017 Jan; 516(1-2):21-31. PubMed ID: 27845215 [TBL] [Abstract][Full Text] [Related]
43. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug. Zhang X; Wang H; Zhang T; Zhou X; Wu B Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461 [TBL] [Abstract][Full Text] [Related]
44. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs. Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438 [TBL] [Abstract][Full Text] [Related]
45. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Mahmood S; Taher M; Mandal UK Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789 [TBL] [Abstract][Full Text] [Related]
46. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach. Moghddam SM; Ahad A; Aqil M; Imam SS; Sultana Y Artif Cells Nanomed Biotechnol; 2017 May; 45(3):617-624. PubMed ID: 27050533 [TBL] [Abstract][Full Text] [Related]
47. Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization. El-Dahmy RM; Elsayed I; Elshafeey AH; Gawad NA; El-Gazayerly ON Int J Pharm; 2014 Dec; 477(1-2):39-46. PubMed ID: 25290813 [TBL] [Abstract][Full Text] [Related]
48. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091 [TBL] [Abstract][Full Text] [Related]
51. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M; Iqbal Z Int J Pharm; 2019 Apr; 560():78-91. PubMed ID: 30742987 [TBL] [Abstract][Full Text] [Related]
52. Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate. Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA Pharm Dev Technol; 2018 Oct; 23(8):787-793. PubMed ID: 28504046 [TBL] [Abstract][Full Text] [Related]
54. Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic-pharmacodynamic modeling approach for quantitative prediction of skin absorption. Elkomy MH; El Menshawe SF; Eid HM; Ali AM Drug Dev Ind Pharm; 2017 Apr; 43(4):531-544. PubMed ID: 27910712 [TBL] [Abstract][Full Text] [Related]
55. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation. Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361 [TBL] [Abstract][Full Text] [Related]
56. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
57. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA Saudi Pharm J; 2017 Nov; 25(7):1040-1046. PubMed ID: 29158713 [TBL] [Abstract][Full Text] [Related]
58. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation. Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581 [TBL] [Abstract][Full Text] [Related]
59. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Song J; Fan X; Shen Q Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353 [TBL] [Abstract][Full Text] [Related]
60. Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment. Tawfik MA; Tadros MI; Mohamed MI; Nageeb El-Helaly S Int J Nanomedicine; 2020; 15():8893-8910. PubMed ID: 33209023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]